Articles From: AVANIR ALERT: Johnson & Weaver, LLP Investigates the Fairness of Price and Process in Proposed Sale of Avanir Pharmaceuticals, Inc. to Otsuka Pharmaceutical to Avery Dennison to Webcast Fourth Quarter and Full-Year 2014 Earnings Conference Call


2014/12/2
Shareholder Rights Law Firm Johnson & Weaver, LLP is investigating whether members of the board of directors of Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) breached their fiduciary duties in connection with the planned merger of the Company with Otsuka Pharmaceutical Co., Ltd.
Sign-up for AVANIR ALERT: Johnson & Weaver, LLP Investigates the Fairness of Price and Process in Proposed Sale of Avanir Pharmaceuticals, Inc. to Otsuka Pharmaceutical investment picks
2014/12/1
ALISO VIEJO, Calif., Dec.
Sign-up for Avanir Pharmaceuticals Announces Date of Fiscal 2014 Fourth Quarter Financial Results and Conference Call investment picks
2014/12/5
ALISO VIEJO, Calif.
Sign-up for Avanir Pharmaceuticals Cancels Previously Scheduled Earnings Call investment picks
2014/12/4
NEW YORK , Dec.
Sign-up for Avanir Pharmaceuticals Inc. Stockholders Encouraged to Contact Securities Law Firm about Takeover investment picks
2014/12/3
Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Avanir Pharmaceuticals, Inc. NEW YORK , Dec.
Sign-up for AVANIR PHARMACEUTICALS SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Avanir Pharmaceuticals, Inc. Over the Proposed Sale of the Company to Otsuka Pharmaceutical Co., Ltd. - AVNR investment picks
2014/12/2
ALISO VIEJO, Calif.
Sign-up for Avanir Pharmaceuticals To Be Acquired By Otsuka Pharmaceutical For $3.5 Billion investment picks
2014/12/2
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Avanir Pharmaceuticals, Inc. (“Avanir”) (NASDAQ:AVNR) concerning the sale to Otsuka Pharmaceutical Co., Ltd.
Sign-up for AVANIR PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Sale to Otsuka Pharmaceutical Co., Ltd. investment picks
2014/12/4
Rigrodsky & Long, P.A.: Do you own shares of Avanir Pharmaceuticals, Inc. (NASDAQ GS: AVNR )? Did you purchase any of your shares prior to December 2, 2014?
Sign-up for AVANIR PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout investment picks
2014/12/2
WILMINGTON, Del.
Sign-up for AVANIR PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout investment picks
2015/2/9
DENVER, Colo., Feb.
Sign-up for Aventura Raises $14 Million Series C Financing Co-Led by Safeguard Scientifics and Merck GHIF investment picks
2015/2/13
Avenue Financial Holdings, Inc. (Nasdaq: AVNU) (“Avenue Financial” or “the Company”) announced today that it has completed its previously announced initial public offering of 2,500,000 shares of its common stock, including 1,324,265 shares sold by the Company and 1,175,735 shares sold by selling stockholders, at a public offering price of $11.00 per share, resulting in aggregate gross proceeds of $27.5 million.
Sign-up for Avenue Financial Holdings, Inc. Announces Closing of Initial Public Offering investment picks
2015/2/26
NASHVILLE, Tenn., Feb.
Sign-up for Avenue Financial Holdings, Inc. Announces Record 2014 Results investment picks
2015/2/23
NASHVILLE, Tenn., Feb.
Sign-up for Avenue Financial Holdings, Inc. Announces Underwriters' Exercise of Over-Allotment Option From Initial Public Offering investment picks
2015/2/2
NEW YORK , Feb.
Sign-up for Avenue Income Credit Strategies Fund April Monthly Dividend investment picks
2014/12/1
NEW YORK , Dec.
Sign-up for Avenue Income Credit Strategies Fund December Monthly Dividend investment picks
2015/2/2
NEW YORK , Feb.
Sign-up for Avenue Income Credit Strategies Fund February Monthly Dividend investment picks
2015/2/2
NEW YORK , Feb.
Sign-up for Avenue Income Credit Strategies Fund March Monthly Dividend investment picks
2015/2/3
NEW YORK , Feb.
Sign-up for Avenue Income Credit Strategies Fund Portfolio Data investment picks
2014/12/19
NEW YORK , Dec.
Sign-up for Avenue Income Credit Strategies Fund Special Year End Distribution And January Monthly Dividend investment picks
2015/1/7
AVEO Oncology (NASDAQ:AVEO) today announced that its Board of Directors has appointed Michael P.
Sign-up for AVEO Announces Executive Transition and Corporate Restructuring investment picks
2015/1/9
AVEO Oncology (NASDAQ:AVEO) today announced the appointment of Michael N.
Sign-up for AVEO Names Michael N. Needle, M.D., As Chief Medical Officer investment picks
2015/2/27
AVEO Oncology (NASDAQ:AVEO) today announced that management will host a conference call and webcast on Friday, March 6, 2015, at 8:00 a.m. Eastern Time to discuss the presentation of final results and a predefined biomarker analysis of its BATON-CRC study, a randomized Phase 2 clinical trial of modified FOLFOX6 combined with tivozanib or bevacizumab in metastatic colorectal cancer.
Sign-up for AVEO Oncology to Host Conference Call to Discuss Presentation of Final Results and Biomarker Analysis from Phase 2 Study of Tivozanib in Patients with Advanced Colorectal Cancer investment picks
2015/1/8
AVEO Oncology (NASDAQ:AVEO) today announced that it has received written confirmation from the European Medicine Agency (EMA) that tivozanib is eligible for submission of an application for a European Union Marketing Authorization under the Agency’s centralized procedure.
Sign-up for AVEO Receives Confirmation of Eligibility for Submission of a Tivozanib Marketing Authorization Application to the European Medicines Agency investment picks
2015/1/12
AVEO Oncology (NASDAQ:AVEO) today announced that Michael P.
Sign-up for AVEO to Present at the 33rd Annual J.P. Morgan Healthcare Conference investment picks
2015/2/10
The average down payment on conventional loan offers made to LendingTree borrowers in Q4 was $47,585, or 17.59% of the loan amount CHARLOTTE, N.C. , Feb.
Sign-up for Average Down Payments Continue to Rise investment picks
2015/2/2
Avery Dennison Corporation (NYSE:AVY) today announced preliminary, unaudited results for its fourth quarter and full year ended January 3, 2015.
Sign-up for Avery Dennison Announces Fourth Quarter and Full Year 2014 Results investment picks
2015/1/28
The Board of Directors of Avery Dennison Corporation (NYSE:AVY) has declared a quarterly cash dividend of $0.35 per share.
Sign-up for Avery Dennison Declares Quarterly Dividend investment picks
2015/2/13
Avery Dennison Corporation (NYSE:AVY) today announced the appointment of Anne L.
Sign-up for Avery Dennison Names Anne L. Bramman Senior Vice President and Chief Financial Officer investment picks
2015/1/22
Avery Dennison Corporation (NYSE:AVY) today announced that Dean A.
Sign-up for Avery Dennison to Present at Investor Conference on February 18, 2015 investment picks
2015/1/28
Avery Dennison Corporation (NYSE:AVY) will host its fourth quarter and full-year 2014 earnings conference call in a live Webcast for investors, equity analysts, portfolio managers and media representatives at 11:00 a.m. Eastern Time/8:00 a.m. Pacific Time on Monday, February 2, 2015.
Sign-up for Avery Dennison to Webcast Fourth Quarter and Full-Year 2014 Earnings Conference Call investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: AVANIR ALERT: Johnson & Weaver, LLP Investigates the Fairness of Price and Process in Proposed Sale of Avanir Pharmaceuticals, Inc. to Otsuka Pharmaceutical to Avery Dennison to Webcast Fourth Quarter and Full-Year 2014 Earnings Conference Call
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent